LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

Начало・Списък с акции・Boston Scientific Corp.

Boston Scientific Corp.

Затворен

Сектор Здравеопазване

81.59 0.31

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

80.8

Максимум

81.95

Ключови измерители
By Trading Economics
Приходи	-168M 324M
Продажби	260M 4.1B
P/E Средно за сектора	64.71 103.001
EPS	0.62
Марж на печалбата	7.864
Служители	48,000
EBITDA	-173M 808M

Препоръки
By TipRanks
Препоръки	Силна покупка
12-месечна прогноза	+7.67 upside

Дивиденти
By Dow Jones
Следващи печалби	24.10.2024 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	617M 120B
Предишно отваряне	81.28
Предишно затваряне	81.59

Настроения в новините

By Acuity

30%

70%

56 / 365 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Bullish Evidence

79.9 / 81.79 Подкрепа & съпротива

Boston Scientific Corp. Графика

Свързани новини

18.06.2024 г., 13:23 ч. UTC

Придобивния, сливания и поглъщания

Correction to Boston Scientific to Buy Silk Road Article

18.06.2024 г., 11:41 ч. UTC

Значими двигатели на пазара

Придобивния, сливания и поглъщания

Silk Road Medical Shares Surge Premarket on Boston Scientific Deal

18.06.2024 г., 11:31 ч. UTC

Придобивния, сливания и поглъщания

Boston Scientific to Buy Silk Road Medical for About $1.26 Billion

24.04.2024 г., 11:01 ч. UTC

Печалби

Boston Scientific Lifts 2024 Outlook After Strong 1Q

24.07.2024 г., 12:02 ч. UTC

Печалби

Boston Scientific Earnings Beat; Medtech Giant Raises Guidance -- IBD

24.07.2024 г., 10:48 ч. UTC

Печалби

Boston Scientific Profit Beats Estimates As Cardiovascular Sales Surge -- MarketWatch

24.07.2024 г., 10:47 ч. UTC

Печалби

GE Vernova Delivers An Earnings Beat With First Results After Separation, Even As Revenue Misses -- MarketWatch

24.07.2024 г., 10:47 ч. UTC

Печалби

Boston Scientific Earnings Beat, Guidance Raised; Medtech Giant Rises -- IBD

24.07.2024 г., 10:33 ч. UTC

Печалби

Boston Scientific Sees 3Q Net Sales Growth of About 13%-15% >BSX

24.07.2024 г., 10:32 ч. UTC

Печалби

Boston Scientific Sees FY Net Sales Growth of About 13.5%-14.5% >BSX

24.07.2024 г., 10:30 ч. UTC

Печалби

Boston Scientific Sees FY EPS $1.34-EPS $1.38 >BSX

24.07.2024 г., 10:30 ч. UTC

Печалби

Boston Scientific Sees FY Adj EPS $2.38-Adj EPS $2.42 >BSX

24.07.2024 г., 10:30 ч. UTC

Печалби

Boston Scientific 2Q Adj EPS 62c >BSX

24.07.2024 г., 10:30 ч. UTC

Печалби

Boston Scientific 2Q EPS 22c >BSX

24.07.2024 г., 10:30 ч. UTC

Печалби

Boston Scientific Sees 3Q Adj EPS 57c-Adj EPS 59c >BSX

24.07.2024 г., 10:30 ч. UTC

Печалби

Boston Scientific Sees 3Q EPS 36c-EPS 38c >BSX

24.07.2024 г., 10:30 ч. UTC

Печалби

Boston Scientific 2Q Sales $4.12B >BSX

18.06.2024 г., 20:22 ч. UTC

Придобивния, сливания и поглъщания

Silk Road Medicine Rockets On Boston Scientific's $1.16 Billion Takeover -- IBD

18.06.2024 г., 14:25 ч. UTC

Придобивния, сливания и поглъщания

Silk Road Medicine Rockets On Boston Scientific's $1.16 Billion Takeover -- IBD

18.06.2024 г., 12:54 ч. UTC

Придобивния, сливания и поглъщания

Silk Road Medicine Rockets On Boston Scientific's $1.16 Billion Takeover -- IBD

18.06.2024 г., 11:33 ч. UTC

Придобивния, сливания и поглъщания

Silk Road Medical Stock Soars. It's Being Acquired by Boston Scientific. -- Barrons.com

18.06.2024 г., 11:18 ч. UTC

Придобивния, сливания и поглъщания

Silk Road Medical Stock Rallies On Boston Scientific Acquisition Deal -- MarketWatch

18.06.2024 г., 11:03 ч. UTC

Придобивния, сливания и поглъщания

Boston Scientific Sees Immaterial Impact to Adjusted EPS In 2024, 2025 >BSX

18.06.2024 г., 11:02 ч. UTC

Придобивния, сливания и поглъщания

Silk Road Medical to Be Acquired for $27.50/Share; Closed Monday at $21.67 >SILK BSX

18.06.2024 г., 11:01 ч. UTC

Придобивния, сливания и поглъщания

Boston Scientific: Silk Road Medical Deal Reflects Enterprise Value of About $1.16 Billion >BSX SILK

18.06.2024 г., 11:01 ч. UTC

Придобивния, сливания и поглъщания

Boston Scientific To Buy Silk Road Medical for $27.50/Share >BSX SILK

18.06.2024 г., 11:00 ч. UTC

Придобивния, сливания и поглъщания

Boston Scientific Announces Agreement To Acquire Silk Road Medical, Inc. >BSX SILK

24.04.2024 г., 12:30 ч. UTC

Топ новини

Печалби

Boston Scientific Stock Rises on More Than Just an Earnings Beat -- Barrons.com

24.04.2024 г., 10:36 ч. UTC

Печалби

Boston Scientific Sees 2024 Sales Up 11%-13%, Organic Sales Up 10%-12% >BSX

24.04.2024 г., 10:35 ч. UTC

Печалби

Boston Scientific Sees 2Q Sales Up 10.5%-12.5%, Organic Sales Up 10%-12% >BSX

Сравнение с други в отрасъла

Ценова промяна

Boston Scientific Corp. Прогноза

Ценова цел

By TipRanks

7.67% нагоре

12-месечна прогноза

Среден 87.61 USD 7.67%

Висок 100 USD

Нисък 78 USD

Според 19 анализатори от Wall Street, предложили 12-месечна ценова цел за Boston Scientific Corp. през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

19 ratings

Купи

Задържане

Продай

Според 19 анализатори, дали борсови рейтинги на Boston Scientific Corp. през последните 3 месеца.

Техническа оценка

By Trading Central

79.9 / 81.79Подкрепа & съпротива

Bullish events outweigh bearish events.

There is one bullish event.

Настроение

By Acuity

56 / 365 Класиране в Здравеопазване

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Boston Scientific Corp.

Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company offers its products by businesses such Interventional Cardiology, Peripheral Interventions, Cardiac Rhythm Management, Electrophysiology, Endoscopy, Urology and Pelvic Health, Neuromodulation and Specialty Pharmaceuticals. It operates in three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. MedSurg consists of Endoscopy and Urology and Pelvic Health businesses. Rhythm segment consists of Cardiac Rhythm Management, Electrophysiology and Neuromodulation businesses. Its Cardiovascular segment consists of Interventional Cardiology and Peripheral Interventions businesses. Its product offerings include balloon catheters, rotational atherectomy systems, guide wires, guide catheters, embolic protection devices and diagnostic catheters used in percutaneous transluminal coronary angioplasty (PTCA) procedures.